InsiderInsights.com Daily Round Up 4/7/16: Ambac Financial, Hubspot, Clayton Williams Energy, Pacific Sunwear Of California

|
Includes: ACN, AMBC, ARLZ, CWEI, DRAD, FAV, GGP, GHY, HUBS, ISD, LIFE, MFRM, MYL, OPK, PSUN, SUM, SYK, VR, VRA
by: InsiderInsights

Summary

Tables of the top insider purchases and sales filed with the SEC on 4/7/16, based on dollar value.

Dollar values often do not equate with significance when it comes to insider trades.

Proprietary Insider Company Ratings are relayed to clarify significance.

Dollar value is only one metric to assess the significance of an insider transaction, but when high dollar value intersects with significance it spotlights a stock investors should take the time to consider. InsiderInsights Daily Round Up articles are intended as initial research tools, so investors can separate real insider investment intelligence from time-wasting noise.

Click the Company Name links in the tables below to analyze a company's or insider's full insider history.

Educational note from InsiderInsights: Insider filing volumes are at a seasonal low point due to companies closing trading windows to their insiders until quarterly earnings are released. As a result, the dollar values of trades featured in our Daily round Up articles (particularly the purchases) will likely be lower than usual until early May.

On Today's Tables:

Insider trades were rated Significant at:

  • Pacific Sunwear Of California (NASDAQ:PSUN);
  • Opko Health (NYSEMKT:OPK);
  • Hubspot (NYSE:HUBS);
  • First Trust Dividend & Income Fund (NYSE:FAV);
  • Clayton Williams Energy (NASDAQ:CWEI), and;
  • Ambac Financial (NASDAQ:AMBC).

Insider trades were rated Nearly Significant at:

  • Atyr Pharma (NASDAQ:LIFE);
  • Pru SD Hi Yld Fd (NYSE:ISD);
  • Aralez Pharm (NASDAQ:ARLZ);
  • Pru Gl SD Hi Yld Fd (NYSE:GHY), and;
  • Summit Materials (NYSE:SUM).

Insider trades were considered Insignificant at:

  • Vera Bradley (NASDAQ:VRA);
  • Validus Holdings (NYSE:VR);
  • Stryker (NYSE:SYK);
  • General Growth Pr (NYSE:GGP), and;
  • Accenture (NYSE:ACN).

There is a Conflicted Insider Signal (both purchases & sales) at:

  • Mylan (NASDAQ:MYL);
  • Mattress Firm (NASDAQ:MFRM), and;
  • Digirad (NASDAQ:DRAD).

Insider Purchases

#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1 Berkshire Partners BO Mattress Firm MFRM B $6,468,609
2 Sullivan James J O Pru SD Hi Yld Fd ISD B $1,000,369
3 Ares Mgt DIR,BO Clayton Williams Energy CWEI B $719,435
4 Sullivan James J O Pru Gl SD Hi Yld Fd GHY B $249,165
5 Nader Tavakoli CEO,DIR Ambac Financial AMBC JB* $240,408
6 Frost Phillip Md CEO,CB,BO Opko Health OPK B $212,157
7 Greene Alexander David DIR Ambac Financial AMBC JB* $150,500
8 Bulldog Investors BO First Trust Dividend & Income Fund FAV B $96,828
9 Schimmel Paul DIR Atyr Pharma LIFE B $80,000
10 Eberwein Jeffrey DIR Digirad DRAD AB $57,476
Click to enlarge

Source: InsiderInsights.com | Key to Insider Title and Trans Type Codes :
B =Open-market Buy; AB=10b5-1 (automatic) Buy; JB*=Buy indicated as being open-market, but not confirmed by trading price range and volume for the session.

Insider Sales

#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1 Qlt BO Aralez Pharm ARLZ JS* $15,000,000
2 Coury Robert J CB,DIR Mylan MYL AS $10,007,171
3 Greenberg Jeffrey DIR Validus Holdings VR AS $8,099,777
4 Lance Howard L DIR Summit Materials SUM S $1,484,250
5 Stryker Ronda E DIR Stryker SYK AS $1,300,112
6 Halligan Brian CEO,DIR Hubspot HUBS AS $828,268
7 Ray Michael C BO Vera Bradley VRA AS $739,450
8 Abu Dhabi Inv BO General Growth Pr GGP S $651,244
9 London Daniel T CEO Accenture ACN AS $613,863
10 Adage Capital Gp BO Pacific Sunwear Of California PSUN S $497,489
Click to enlarge

InsiderInsights.com | Key to Insider Title and Trans Type Codes :
S =Open-market Sale; AS=10b5-1 (automatic) Sale; JS*=Sale indicated as being open-market, but not confirmed by trading price range and volume for the session.

Disclosure: I am/we are long OPK.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Editor's Note: This article covers one or more stocks trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.